We’re pleased to share that Dr. Gregory Penner, Chief Scientific Officer at NeoVentures Biotechnology Europe, will be participating in BIO-Europe Fall 2025, taking place November 3-5 in Vienna, Austria.

BIO-Europe Fall is Europe’s leading partnering conference for the global biotech and pharmaceutical industries, bringing together innovators, investors, and strategic partners to advance scientific and commercial collaborations.

At this year’s event, Dr. Penner will meet with potential partners to discuss NeoVentures’ Aptamarker platform, our proprietary system for biomarker discovery that leverages aptamer technology to identify and validate molecular signatures of disease with precision and reproducibility.